News

NEWS
Publication
November 28, 2016
A New Mathematical Model of the Eosinophil Lifecycle Shows Irrelevance of the Asthma Biomarker Choice
Moscow, Russia - November 29th, 2016. Institute for Systems Biology Moscow (www.insysbio.ru), one of the pioneers in bio-modeling and simulation announced the study made in collaboration with scientists of two pharmaceutical leaders: MedImmune and AstraZeneca.
LEARN MORE
October 2025
MoTuWeThFrSaSu
  
1
2
1. 02 Oct 2025 13:23 InSysBio to announce participation in BioTechX Europe 2025 with focus on AI and QSP InSysBio announces their participation in BioTechX Europe 2025. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges"
3
4
5
6
7
8
9
10
11
12
13
14
15
16
1. 16 Oct 2025 12:13 InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
  
Upcoming Events
18.10
InSysBio to participate in ACoP 2025
Tags